标题
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 118, Issue 9, Pages e2022830118
出版商
Proceedings of the National Academy of Sciences
发表日期
2021-02-25
DOI
10.1073/pnas.2022830118
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
- (2020) Guoxuan Gao et al. BMC CANCER
- Givosiran: First Approval
- (2020) Lesley J. Scott DRUGS
- Crosstalk between HER2 and PD-1/PD-L1 in Breast Cancer: From Clinical Applications to Mathematical Models
- (2020) Regina Padmanabhan et al. Cancers
- CD47 Ligation Repositions the Inhibitory Receptor SIRPA to Suppress Integrin Activation and Phagocytosis
- (2020) Meghan A. Morrissey et al. IMMUNITY
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer
- (2019) Constantia Pantelidou et al. Cancer Discovery
- Current Landscape of Immunotherapy in Breast Cancer
- (2019) Sylvia Adams et al. JAMA Oncology
- Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors
- (2019) Sophia C Weinmann et al. RHEUMATOLOGY
- Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity
- (2019) Greta Garrido et al. Nature Communications
- Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
- (2018) Koji Takada et al. Journal of Translational Medicine
- Tapping the RNA world for therapeutics
- (2018) Judy Lieberman NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MCL-1 is a prognostic indicator and drug target in breast cancer
- (2018) Kirsteen J. Campbell et al. Cell Death & Disease
- Tapping the RNA world for therapeutics
- (2018) Judy Lieberman NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Metastatic and triple-negative breast cancer: challenges and treatment options
- (2018) Sumayah Al-Mahmood et al. Drug Delivery and Translational Research
- Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
- (2018) Yannick Simoni et al. NATURE
- 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
- (2017) David Cameron et al. LANCET
- Basal-A Triple-Negative Breast Cancer Cells Selectively Rely on RNA Splicing for Survival
- (2017) Stefanie Chan et al. MOLECULAR CANCER THERAPEUTICS
- Aptamers as targeted therapeutics: current potential and challenges
- (2017) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of enhanced metabolic stability on pharmacokinetics and pharmacodynamics of GalNAc–siRNA conjugates
- (2017) Jayaprakash K. Nair et al. NUCLEIC ACIDS RESEARCH
- Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and Immunotherapies
- (2017) Géraldine Genard et al. Frontiers in Immunology
- The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
- (2016) J Turpin et al. ONCOGENE
- TREX1 Knockdown Induces an Interferon Response to HIV that Delays Viral Infection in Humanized Mice
- (2016) Lee Adam Wheeler et al. Cell Reports
- An overview of triple-negative breast cancer
- (2015) Pankaj Kumar et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Manipulating the in vivo immune response by targeted gene knockdown
- (2015) Judy Lieberman CURRENT OPINION IN IMMUNOLOGY
- Cancer immunotherapy: harnessing the immune system to battle cancer
- (2015) Yiping Yang JOURNAL OF CLINICAL INVESTIGATION
- Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells
- (2015) A. Gilboa-Geffen et al. MOLECULAR CANCER THERAPEUTICS
- CD47 blockade triggers T cell–mediated destruction of immunogenic tumors
- (2015) Xiaojuan Liu et al. NATURE MEDICINE
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- Immune evasion in cancer: Mechanistic basis and therapeutic strategies
- (2015) Dass S. Vinay et al. SEMINARS IN CANCER BIOLOGY
- Attenuation of nonsense-mediated mRNA decay facilitates the response to chemotherapeutics
- (2015) Maximilian W. Popp et al. Nature Communications
- A Genome-wide siRNA Screen Identifies Proteasome Addiction as a Vulnerability of Basal-like Triple-Negative Breast Cancer Cells
- (2013) Fabio Petrocca et al. CANCER CELL
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response
- (2013) D. Tseng et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Sequence analysis of mutations and translocations across breast cancer subtypes
- (2012) Shantanu Banerji et al. NATURE
- Identification of hundreds of novel UPF1 target transcripts by direct determination of whole transcriptome stability
- (2012) Hidenori Tani et al. RNA Biology
- EpCAM and its potential role in tumor-initiating cells
- (2012) Sannia Imrich et al. Cell Adhesion & Migration
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Nonsense-Mediated RNA Decay Regulation by Cellular Stress: Implications for Tumorigenesis
- (2010) L. B. Gardner MOLECULAR CANCER RESEARCH
- Induction of tumour immunity by targeted inhibition of nonsense-mediated mRNA decay
- (2010) Fernando Pastor et al. NATURE
- Hypoxic Inhibition of Nonsense-Mediated RNA Decay Regulates Gene Expression and the Integrated Stress Response
- (2008) L. B. Gardner MOLECULAR AND CELLULAR BIOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started